Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe High Potency API Market Report 2017

  • QYR983115
  • 125 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of High Potency API

Revenue, means the sales value of High Potency API

This report studies sales (consumption) of High Potency API in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer

Novartis International

Sanofi

Boehringer Ingelheim

Bristol-Myers Squibb

Teva Pharmaceutical

Eli Lilly and Company

GlaxoSmithKline

Merck & Co

AbbVie

Johnson & Johnson

Bayer

Mylan

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of High Potency API in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Synthetic HPAPIs

Biotech HPAPIs

Split by application, this report focuses on sales, market share and growth rate of High Potency API in each application, can be divided into

Oncology

Hormonal Disorders

Glaucoma

Other

Table of Contents

Europe High Potency API Market Report 2017

1 High Potency API Overview

1.1 Product Overview and Scope of High Potency API

1.2 Classification of High Potency API

1.2.1 Synthetic HPAPIs

1.2.2 Biotech HPAPIs

1.3 Application of High Potency API

1.3.1 Oncology

1.3.2 Hormonal Disorders

1.3.3 Glaucoma

1.3.4 Other

1.4 High Potency API Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of High Potency API (2012-2022)

1.5.1 Europe High Potency API Sales and Growth Rate (2012-2022)

1.5.2 Europe High Potency API Revenue and Growth Rate (2012-2022)

2 Europe High Potency API by Manufacturers, Type and Application

2.1 Europe High Potency API Market Competition by Manufacturers

2.1.1 Europe High Potency API Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe High Potency API Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe High Potency API (Volume and Value) by Type

2.2.1 Europe High Potency API Sales and Market Share by Type (2012-2017)

2.2.2 Europe High Potency API Revenue and Market Share by Type (2012-2017)

2.3 Europe High Potency API (Volume and Value) by Countries

2.3.1 Europe High Potency API Sales and Market Share by Countries (2012-2017)

2.3.2 Europe High Potency API Revenue and Market Share by Countries (2012-2017)

2.4 Europe High Potency API (Volume) by Application

3 Germany High Potency API (Volume, Value and Sales Price)

3.1 Germany High Potency API Sales and Value (2012-2017)

3.1.1 Germany High Potency API Sales and Growth Rate (2012-2017)

3.1.2 Germany High Potency API Revenue and Growth Rate (2012-2017)

3.1.3 Germany High Potency API Sales Price Trend (2012-2017)

3.2 Germany High Potency API Sales and Market Share by Manufacturers

3.3 Germany High Potency API Sales and Market Share by Type

3.4 Germany High Potency API Sales and Market Share by Application

4 France High Potency API (Volume, Value and Sales Price)

4.1 France High Potency API Sales and Value (2012-2017)

4.1.1 France High Potency API Sales and Growth Rate (2012-2017)

4.1.2 France High Potency API Revenue and Growth Rate (2012-2017)

4.1.4 France High Potency API Sales Price Trend (2012-2017)

4.2 France High Potency API Sales and Market Share by Manufacturers

4.3 France High Potency API Sales and Market Share by Type

4.4 France High Potency API Sales and Market Share by Application

5 UK High Potency API (Volume, Value and Sales Price)

5.1 UK High Potency API Sales and Value (2012-2017)

5.1.1 UK High Potency API Sales and Growth Rate (2012-2017)

5.1.2 UK High Potency API Revenue and Growth Rate (2012-2017)

5.1.5 UK High Potency API Sales Price Trend (2012-2017)

5.2 UK High Potency API Sales and Market Share by Manufacturers

5.3 UK High Potency API Sales and Market Share by Type

5.4 UK High Potency API Sales and Market Share by Application

6 Russia High Potency API (Volume, Value and Sales Price)

6.1 Russia High Potency API Sales and Value (2012-2017)

6.1.1 Russia High Potency API Sales and Growth Rate (2012-2017)

6.1.2 Russia High Potency API Revenue and Growth Rate (2012-2017)

6.1.6 Russia High Potency API Sales Price Trend (2012-2017)

6.2 Russia High Potency API Sales and Market Share by Manufacturers

6.3 Russia High Potency API Sales and Market Share by Type

6.4 Russia High Potency API Sales and Market Share by Application

7 Italy High Potency API (Volume, Value and Sales Price)

7.1 Italy High Potency API Sales and Value (2012-2017)

7.1.1 Italy High Potency API Sales and Growth Rate (2012-2017)

7.1.2 Italy High Potency API Revenue and Growth Rate (2012-2017)

7.1.7 Italy High Potency API Sales Price Trend (2012-2017)

7.2 Italy High Potency API Sales and Market Share by Manufacturers

7.3 Italy High Potency API Sales and Market Share by Type

7.4 Italy High Potency API Sales and Market Share by Application

8 Spain High Potency API (Volume, Value and Sales Price)

8.1 Spain High Potency API Sales and Value (2012-2017)

8.1.1 Spain High Potency API Sales and Growth Rate (2012-2017)

8.1.2 Spain High Potency API Revenue and Growth Rate (2012-2017)

8.1.8 Spain High Potency API Sales Price Trend (2012-2017)

8.2 Spain High Potency API Sales and Market Share by Manufacturers

8.3 Spain High Potency API Sales and Market Share by Type

8.4 Spain High Potency API Sales and Market Share by Application

9 Benelux High Potency API (Volume, Value and Sales Price)

9.1 Benelux High Potency API Sales and Value (2012-2017)

9.1.1 Benelux High Potency API Sales and Growth Rate (2012-2017)

9.1.2 Benelux High Potency API Revenue and Growth Rate (2012-2017)

9.1.9 Benelux High Potency API Sales Price Trend (2012-2017)

9.2 Benelux High Potency API Sales and Market Share by Manufacturers

9.3 Benelux High Potency API Sales and Market Share by Type

9.4 Benelux High Potency API Sales and Market Share by Application

10 Europe High Potency API Manufacturers Analysis

10.1 Pfizer

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 High Potency API Product Type, Application and Specification

10.1.2.1 Synthetic HPAPIs

10.1.2.2 Biotech HPAPIs

10.1.3 Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Novartis International

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 High Potency API Product Type, Application and Specification

10.2.2.1 Synthetic HPAPIs

10.2.2.2 Biotech HPAPIs

10.2.3 Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Sanofi

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 High Potency API Product Type, Application and Specification

10.3.2.1 Synthetic HPAPIs

10.3.2.2 Biotech HPAPIs

10.3.3 Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Boehringer Ingelheim

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 High Potency API Product Type, Application and Specification

10.4.2.1 Synthetic HPAPIs

10.4.2.2 Biotech HPAPIs

10.4.3 Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Bristol-Myers Squibb

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 High Potency API Product Type, Application and Specification

10.5.2.1 Synthetic HPAPIs

10.5.2.2 Biotech HPAPIs

10.5.3 Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Teva Pharmaceutical

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 High Potency API Product Type, Application and Specification

10.6.2.1 Synthetic HPAPIs

10.6.2.2 Biotech HPAPIs

10.6.3 Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Eli Lilly and Company

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 High Potency API Product Type, Application and Specification

10.7.2.1 Synthetic HPAPIs

10.7.2.2 Biotech HPAPIs

10.7.3 Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 GlaxoSmithKline

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 High Potency API Product Type, Application and Specification

10.8.2.1 Synthetic HPAPIs

10.8.2.2 Biotech HPAPIs

10.8.3 GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Merck & Co

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 High Potency API Product Type, Application and Specification

10.9.2.1 Synthetic HPAPIs

10.9.2.2 Biotech HPAPIs

10.9.3 Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 AbbVie

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 High Potency API Product Type, Application and Specification

10.10.2.1 Synthetic HPAPIs

10.10.2.2 Biotech HPAPIs

10.10.3 AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 Johnson & Johnson

10.12 Bayer

10.13 Mylan

11 High Potency API Manufacturing Cost Analysis

11.1 High Potency API Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of High Potency API

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 High Potency API Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of High Potency API Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe High Potency API Market Forecast (2017-2022)

14.1 Germany High Potency API Sales Forecast (2017-2022)

14.2 France High Potency API Sales Forecast (2017-2022)

14.3 UK High Potency API Sales Forecast (2017-2022)

14.4 Russia High Potency API Sales Forecast (2017-2022)

14.5 Italy High Potency API Sales Forecast (2017-2022)

14.6 Spain High Potency API Sales Forecast (2017-2022)

14.7 Benelux High Potency API Sales Forecast (2017-2022)

14.8 Europe High Potency API Sales Forecast by Type (2017-2022)

14.9 Europe High Potency API Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of High Potency API

Table Classification of High Potency API

Figure Europe Sales Market Share of High Potency API by Type in 2015

Figure Synthetic HPAPIs Picture

Figure Biotech HPAPIs Picture

Table Application of High Potency API

Figure Europe Sales Market Share of High Potency API by Application in 2015

Figure Oncology Examples

Figure Hormonal Disorders Examples

Figure Glaucoma Examples

Figure Other Examples

Figure Germany High Potency API Revenue and Growth Rate (2012-2022)

Figure France High Potency API Revenue and Growth Rate (2012-2022)

Figure UK High Potency API Revenue and Growth Rate (2012-2022)

Figure Russia High Potency API Revenue and Growth Rate (2012-2022)

Figure Italy High Potency API Revenue and Growth Rate (2012-2022)

Figure Spain High Potency API Revenue and Growth Rate (2012-2022)

Figure Benelux High Potency API Revenue and Growth Rate (2012-2022)

Figure Europe High Potency API Sales and Growth Rate (2012-2022)

Figure Europe High Potency API Revenue and Growth Rate (2012-2022)

Table Europe High Potency API Sales of Key Manufacturers (2015 and 2016)

Table Europe High Potency API Sales Share by Manufacturers (2015 and 2016)

Figure 2015 High Potency API Sales Share by Manufacturers

Figure 2016 High Potency API Sales Share by Manufacturers

Table Europe High Potency API Revenue by Manufacturers (2015 and 2016)

Table Europe High Potency API Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe High Potency API Revenue Share by Manufacturers

Table 2016 Europe High Potency API Revenue Share by Manufacturers

Table Europe High Potency API Sales and Market Share by Type (2012-2017)

Table Europe High Potency API Sales Share by Type (2012-2017)

Figure Sales Market Share of High Potency API by Type (2012-2017)

Figure Europe High Potency API Sales Growth Rate by Type (2012-2017)

Table Europe High Potency API Revenue and Market Share by Type (2012-2017)

Table Europe High Potency API Revenue Share by Type (2012-2017)

Figure Revenue Market Share of High Potency API by Type (2012-2017)

Figure Europe High Potency API Revenue Growth Rate by Type (2012-2017)

Table Europe High Potency API Sales and Market Share by Countries (2012-2017)

Table Europe High Potency API Sales Share by Countries (2012-2017)

Figure Sales Market Share of High Potency API by Countries (2012-2017)

Table Europe High Potency API Revenue and Market Share by Countries (2012-2017)

Table Europe High Potency API Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of High Potency API by Countries (2012-2017)

Table Europe High Potency API Sales and Market Share by Application (2012-2017)

Table Europe High Potency API Sales Share by Application (2012-2017)

Figure Sales Market Share of High Potency API by Application (2012-2017)

Figure Germany High Potency API Sales and Growth Rate (2012-2017)

Figure Germany High Potency API Revenue and Growth Rate (2012-2017)

Figure Germany High Potency API Sales Price Trend (2012-2017)

Table Germany High Potency API Sales by Manufacturers (2015 and 2016)

Table Germany High Potency API Market Share by Manufacturers (2015 and 2016)

Table Germany High Potency API Sales by Type (2015 and 2016)

Table Germany High Potency API Market Share by Type (2015 and 2016)

Table Germany High Potency API Sales by Application (2015 and 2016)

Table Germany High Potency API Market Share by Application (2015 and 2016)

Figure France High Potency API Sales and Growth Rate (2012-2017)

Figure France High Potency API Revenue and Growth Rate (2012-2017)

Figure France High Potency API Sales Price Trend (2012-2017)

Table France High Potency API Sales by Manufacturers (2015 and 2016)

Table France High Potency API Market Share by Manufacturers (2015 and 2016)

Table France High Potency API Sales by Type (2015 and 2016)

Table France High Potency API Market Share by Type (2015 and 2016)

Table France High Potency API Sales by Application (2015 and 2016)

Table France High Potency API Market Share by Application (2015 and 2016)

Figure UK High Potency API Sales and Growth Rate (2012-2017)

Figure UK High Potency API Revenue and Growth Rate (2012-2017)

Figure UK High Potency API Sales Price Trend (2012-2017)

Table UK High Potency API Sales by Manufacturers (2015 and 2016)

Table UK High Potency API Market Share by Manufacturers (2015 and 2016)

Table UK High Potency API Sales by Type (2015 and 2016)

Table UK High Potency API Market Share by Type (2015 and 2016)

Table UK High Potency API Sales by Application (2015 and 2016)

Table UK High Potency API Market Share by Application (2015 and 2016)

Figure Russia High Potency API Sales and Growth Rate (2012-2017)

Figure Russia High Potency API Revenue and Growth Rate (2012-2017)

Figure Russia High Potency API Sales Price Trend (2012-2017)

Table Russia High Potency API Sales by Manufacturers (2015 and 2016)

Table Russia High Potency API Market Share by Manufacturers (2015 and 2016)

Table Russia High Potency API Sales by Type (2015 and 2016)

Table Russia High Potency API Market Share by Type (2015 and 2016)

Table Russia High Potency API Sales by Application (2015 and 2016)

Table Russia High Potency API Market Share by Application (2015 and 2016)

Figure Italy High Potency API Sales and Growth Rate (2012-2017)

Figure Italy High Potency API Revenue and Growth Rate (2012-2017)

Figure Italy High Potency API Sales Price Trend (2012-2017)

Table Italy High Potency API Sales by Manufacturers (2015 and 2016)

Table Italy High Potency API Market Share by Manufacturers (2015 and 2016)

Table Italy High Potency API Sales by Type (2015 and 2016)

Table Italy High Potency API Market Share by Type (2015 and 2016)

Table Italy High Potency API Sales by Application (2015 and 2016)

Table Italy High Potency API Market Share by Application (2015 and 2016)

Figure Spain High Potency API Sales and Growth Rate (2012-2017)

Figure Spain High Potency API Revenue and Growth Rate (2012-2017)

Figure Spain High Potency API Sales Price Trend (2012-2017)

Table Spain High Potency API Sales by Manufacturers (2015 and 2016)

Table Spain High Potency API Market Share by Manufacturers (2015 and 2016)

Table Spain High Potency API Sales by Type (2015 and 2016)

Table Spain High Potency API Market Share by Type (2015 and 2016)

Table Spain High Potency API Sales by Application (2015 and 2016)

Table Spain High Potency API Market Share by Application (2015 and 2016)

Figure Benelux High Potency API Sales and Growth Rate (2012-2017)

Figure Benelux High Potency API Revenue and Growth Rate (2012-2017)

Figure Benelux High Potency API Sales Price Trend (2012-2017)

Table Benelux High Potency API Sales by Manufacturers (2015 and 2016)

Table Benelux High Potency API Market Share by Manufacturers (2015 and 2016)

Table Benelux High Potency API Sales by Type (2015 and 2016)

Table Benelux High Potency API Market Share by Type (2015 and 2016)

Table Benelux High Potency API Sales by Application (2015 and 2016)

Table Benelux High Potency API Market Share by Application (2015 and 2016)

Table High Potency API Basic Information List

Table Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer High Potency API Sales Market Share (2012-2017)

Table Novartis International Basic Information List

Table Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis International High Potency API Sales Market Share (2012-2017)

Table Sanofi Basic Information List

Table Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi High Potency API Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim High Potency API Sales Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bristol-Myers Squibb High Potency API Sales Market Share (2012-2017)

Table Teva Pharmaceutical Basic Information List

Table Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Teva Pharmaceutical High Potency API Sales Market Share (2012-2017)

Table Eli Lilly and Company Basic Information List

Table Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lilly and Company High Potency API Sales Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline High Potency API Sales Market Share (2012-2017)

Table Merck & Co Basic Information List

Table Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck & Co High Potency API Sales Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)

Table AbbVie High Potency API Sales Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Bayer Basic Information List

Table Mylan Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Potency API

Figure Manufacturing Process Analysis of High Potency API

Figure High Potency API Industrial Chain Analysis

Table Raw Materials Sources of High Potency API Major Manufacturers in 2015

Table Major Buyers of High Potency API

Table Distributors/Traders List

Figure Germany High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure Germany High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure France High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure France High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure UK High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure UK High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure Russia High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure Russia High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure Italy High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure Italy High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure Spain High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure Spain High Potency API Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux High Potency API Sales and Growth Rate Forecast (2017-2022)

Figure Benelux High Potency API Revenue and Growth Rate Forecast (2017-2022)

Table Europe High Potency API Sales Forecast by Type (2017-2022)

Table Europe High Potency API Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370